Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat

Neuropharmacology

Volumn 26, Issue 9, 1987, Pages 1431-1440

  Colpaert, F C ^a  

^a Department of Psychopharmacology Janssen Pharmaceutica B 2340 Beerse Belgium ^*

Author keywords

hypokinesia; motor signs; Parkinson's disease; rat; reserpine; rigidity; tremor

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBIDOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; RESERPINE;

ANIMAL MODEL; BIOLOGICAL MODEL; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG RESPONSE; HYPOKINESIA; NONHUMAN; PARKINSON DISEASE; PHARMACOKINETICS; RAT; RIGIDITY; SUBCUTANEOUS DRUG ADMINISTRATION; TREMOR;

ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HALOPERIDOL; LEVODOPA; MONOAMINE OXIDASE INHIBITORS; MOVEMENT DISORDERS; MUSCLE RIGIDITY; RATS; RATS, INBRED STRAINS; RECEPTORS, ADRENERGIC; RESERPINE; SUPPORT, NON-U.S. GOV'T; SWIMMING; SYMPATHOLYTICS; TIME FACTORS; TREMOR;

EID: 0023241854     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(87)90110-9     Document Type: Article

References (52)

1. Pharacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain
2. Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity
3. Norepinephrine-dopamine interactions and behavior
4. A survey of drug-induced extrapyramidal reactions
5. Kinésie paradoxale. Mutisme parkinsonien
6. Dopamine agonists and Parkinson's disease
7. Maximal magnitude of effect and potency of α-adrenoceptor agonists in causing CNS depression, in relaxing muscle, and in lowering body temperature in rat
8. Effects of putative α-adrenoceptor antagonists and of other compounds on the loss of the righting reflex and on exophthalmia induced by xylazine in the rat
9. The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, and LSD antagonist
10. Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat
11. Basal ganglia and Parkinson's disease: neurobiological and pharmacological aspects in animals and man
12. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or α-methyl-p-tyrosine pre-treated mice
13. Verteilung von Noradrenalin und Dopamin (3-hydroxytramin) in Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems
14. Etude anatomopathologique de syndromes parkinsoniens
15. Clinical effectiveness of reserpine
16. Effects of clonidine, piperoxane and locus coeruleus lesion on the serotonergic and dopaminergic systems in raphe and caudate nucleus
17. Some aspects of the effects of acute reserpine treatment on behaviour
18. The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats
19. Zur Pathologie der Paralysis agitans und des Postenzephalitischen parkinsonismus
20. Brain neurotransmitter changes in Parkinson's disease
21. Problems of levodopa treatment
22. 2-antagonistic effects of some dopamine receptor agonists and antagonists
23. The pharmacology of haloperidol
24. A mechanographic method for measurement of muscle tone in the conscious rat. The calf muscle stretch response in reserpine-induced rigidity
25. A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine
26. Striatal monoamines and reserpine and chlorpromazine rigidity
27. Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity
28. The pharmacology of parkinsonism
29. What to do when Sinemet fails: part one
30. Use of reserpine in a neuropsychiatric hospital
31. Origin and organization of brainstem catecholamine innervation in the rat
32. Drug-induced experimental parkinsonism
33. Reserpine rigidity and adrenergic neurones
34. 1) antagonists in the rat
35. Is there an interaction between dopamine and noradrenaline containing neurons in the brain?
36. Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain
37. Noradrenaline and dopamine interaction in rat brain during development
38. Anti-Parkinsonian drugs today
39. Recent physiological and pathophysiological aspects of parkinsonian movement disorders
40. Parkinson's disease
41. Adverse effects of antipsychotic agents
42. On the theory of scales of measurement
43. Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles
44. 2-and dopamine-receptor-mediated inhibitory mechanisms and dopamine nerve terminals in the rat hypothalamus
45. Prevention of reserpine rigidity by alpha-2 adrenergic antagonists
46. Functional and structural observations on chronically reserpinized monkeys
47. Modulatory actions of norepinephrine in the central nervous system
48. Genetics, ageing and dementia
49. Parkinson's disease: studies with an animal model